Correlation Between ContextVision and PCI Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ContextVision and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ContextVision and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ContextVision AB and PCI Biotech Holding, you can compare the effects of market volatilities on ContextVision and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ContextVision with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ContextVision and PCI Biotech.

Diversification Opportunities for ContextVision and PCI Biotech

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between ContextVision and PCI is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding ContextVision AB and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and ContextVision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ContextVision AB are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of ContextVision i.e., ContextVision and PCI Biotech go up and down completely randomly.

Pair Corralation between ContextVision and PCI Biotech

Assuming the 90 days trading horizon ContextVision AB is expected to under-perform the PCI Biotech. But the stock apears to be less risky and, when comparing its historical volatility, ContextVision AB is 2.86 times less risky than PCI Biotech. The stock trades about -0.04 of its potential returns per unit of risk. The PCI Biotech Holding is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  282.00  in PCI Biotech Holding on September 1, 2024 and sell it today you would lose (132.00) from holding PCI Biotech Holding or give up 46.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.63%
ValuesDaily Returns

ContextVision AB  vs.  PCI Biotech Holding

 Performance 
       Timeline  
ContextVision AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ContextVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
PCI Biotech Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PCI Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

ContextVision and PCI Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ContextVision and PCI Biotech

The main advantage of trading using opposite ContextVision and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ContextVision position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.
The idea behind ContextVision AB and PCI Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals